Concepedia

Seongjung Joo

SJ

Statistics

Publications

6

Citations

211

H-Index

6

Active since

2010

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Johns Hopkins University

Georgetown University

Johns Hopkins Medicine

Nema Research (United States)

Seongjung Joo is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pain research, pain medicine, and pharmacotherapy.

Top concepts

Publications per year

2010–2022

6

Publications

6

Prevalence of Exposure to Potential CYP450 Pharmacokinetic Drug–Drug Interactions among Patients with Chronic Low Back Pain Taking Opioids

Joseph V. Pergolizzi, Sumedha Labhsetwar, R. Puenpatom et al. · Pain Practice · 2010 · 57 citations

, , +15

Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study

Viktor Grünwald, Diana Chirovsky, Winson Y. Cheung et al. · Oral Oncology · 2020 · 50 citations · Full text

Exposure to Potential CYP450 Pharmacokinetic Drug–Drug Interactions among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions

Joseph V. Pergolizzi, Sumedha Labhsetwar, R. Puenpatom et al. · Pain Practice · 2010 · 42 citations

, , +19

Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data

E. Alemao, Seongjung Joo, Hugh Kawabata et al. · Arthritis Care & Research · 2015 · 32 citations · Full text

Treatment Patterns and Outcomes Among Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Eric Nadler, Seongjung Joo, Marley Boyd et al. · Future Oncology · 2018 · 18 citations

1–5 of 6